Mackenzie Financial Corp Acquires 25,182 Shares of Waters Corporation $WAT

Mackenzie Financial Corp lifted its holdings in shares of Waters Corporation (NYSE:WAT) by 12.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 231,852 shares of the medical instruments supplier’s stock after purchasing an additional 25,182 shares during the quarter. Mackenzie Financial Corp owned approximately 0.39% of Waters worth $69,512,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Mawer Investment Management Ltd. boosted its holdings in Waters by 225.5% in the third quarter. Mawer Investment Management Ltd. now owns 1,551,010 shares of the medical instruments supplier’s stock worth $465,008,000 after purchasing an additional 1,074,449 shares in the last quarter. Alliancebernstein L.P. raised its holdings in Waters by 31.0% during the second quarter. Alliancebernstein L.P. now owns 4,021,358 shares of the medical instruments supplier’s stock valued at $1,403,615,000 after buying an additional 950,687 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Waters by 44.3% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,689,693 shares of the medical instruments supplier’s stock valued at $806,397,000 after buying an additional 825,723 shares in the last quarter. Norges Bank acquired a new stake in shares of Waters in the second quarter worth about $266,384,000. Finally, Veritas Asset Management LLP acquired a new stake in shares of Waters in the third quarter worth about $175,320,000. Institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

WAT has been the topic of a number of analyst reports. Citigroup started coverage on Waters in a report on Tuesday, February 10th. They set a “buy” rating and a $425.00 price objective on the stock. Bank of America reduced their target price on Waters from $410.00 to $350.00 and set a “neutral” rating for the company in a report on Tuesday, February 10th. Wells Fargo & Company decreased their target price on Waters from $415.00 to $355.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 11th. HSBC initiated coverage on Waters in a report on Tuesday, January 27th. They set a “buy” rating and a $460.00 price target on the stock. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Waters in a research note on Wednesday, January 21st. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $393.84.

Waters Trading Down 0.7%

Waters stock opened at $297.65 on Thursday. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $414.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.73. The firm has a market capitalization of $29.20 billion, a PE ratio of 27.64, a PEG ratio of 2.06 and a beta of 1.20. The business’s 50-day simple moving average is $356.51 and its 200-day simple moving average is $351.37.

Waters (NYSE:WAT) last announced its earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share for the quarter, beating the consensus estimate of $4.50 by $0.03. The firm had revenue of $932.36 million during the quarter, compared to the consensus estimate of $928.17 million. Waters had a return on equity of 34.79% and a net margin of 20.30%.The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.10 EPS. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Equities research analysts forecast that Waters Corporation will post 12.86 earnings per share for the current year.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.